Coloplast (LSE:0QBO) has inaugurated a 50,000 square metre continence care factory in Felgueiras, Portugal, after investing about EUR 100 million. The company says the site gives it the capacity to meet the targets in its current 2030 strategy without building another factory.

What was announced

Coloplast A/S said on 29 October 2026 that it has opened a new factory in Felgueiras, Portugal, to support its global growth. The inauguration took place the same day and was attended by national and local authorities, Coloplast leadership and employees. Production at the site is already underway.

The plant will make continence care products. The company says the expansion is needed to meet growing global demand, and it links the investment to its long-term ambition of helping four million people around the world.

The numbers

Coloplast has invested about EUR 100 million in the project. The two-floor site covers 50,000 square metres, which the company says makes it its largest manufacturing site to date. More than 300 people already work there, and Coloplast expects the workforce to grow to more than 800 in the region over time.

Planning began in 2021 and construction started in summer 2024. The build was completed in just over two years. Frank Berg Rasmussen, Vice President, Manufacturing Portugal, said the Portuguese team's work meant the factory could open "exactly as planned". He added that construction had been completed and production established in about two years.

The announcement does not give production volumes, the capacity in units, the expected revenue contribution, the depreciation profile or any effect on margins. It also does not say when the site is expected to reach full output.

Strategic rationale

The company gives several reasons for choosing Portugal. Until now its European production has been concentrated in Hungary, so the new plant spreads its manufacturing footprint more widely. Europe is where most of Coloplast's users are today, and the company expects demand there to keep growing, so the site also brings production closer to its main market.

Allan Rasmussen, Executive Vice President, Global Operations, said: "Portugal has a qualified and highly trained labour force as well as a competitive cost level." Coloplast also pointed to Portugal's large supply of renewable electricity and its aim to be carbon neutral by 2045.

The most significant point for investors is the company's statement that Felgueiras provides enough capacity to reach its targets within the current 2030 strategy period without any additional manufacturing sites. That suggests no further large factory projects are planned during that period, although the announcement does not discuss future capital expenditure levels.

Ana Casaca, President of AICEP, the Portuguese Trade and Investment Agency, which helped Coloplast set up the site, said the investment shows confidence in the country's ability to attract and deliver strategic industrial investments.

Global footprint and what to watch next

With Portugal added, Coloplast now runs high-volume production in Hungary, China, Costa Rica and Portugal. It has specialised production in the United States, France, Germany, Sweden and Iceland, and an innovation and pilot plant in Denmark.

Investors will want to see how quickly Felgueiras ramps up towards its planned workforce of more than 800 people. They will also look for any information on how the extra capacity, and the shift of some European production away from Hungary, affects gross margins and supply resilience. The company did not provide financial guidance in this announcement. Updates on the ramp-up and capital spending would normally be expected in Coloplast's regular financial reporting. Another point to watch is whether the site reaches its planned scale on schedule, given the company's statement that it should cover capacity needs for the rest of the 2030 strategy period.